Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
To assess the potential role of Tie2 and its ligands angiopoietin-1 and angiopoietin-2 in tumor vascularization, we analyzed their expression pattern in human gliomas.
|
9811337 |
1998 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Tie2 was shown to be upregulated in tumors and skin wounds, and its ligands angiopoietin-1 and -2, although they are not directly mitogenic, modulate neovascularization.
|
10969034 |
2000 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
However, in contrast to its physiological role as promoter of angiogenesis, overexpression of Ang1 did not enhance tumour growth, but instead caused up to a 3-fold retardation of tumour growth (P = 0.003).
|
11027428 |
2000 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Tumors produced by the Ang-1 transfectants had fewer vessels and lower tumor cell proliferative indices than tumors in the other groups.
|
11245414 |
2001 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Ang1 expression was found in a few astrocytes scattered in the tumor at all stages of astrocytoma progression.
|
11304469 |
2001 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
There was a significant reduction in expression of tumor Ang-1 (P = 0.04), Ang-2 (P = 0.01), Ang-4 (P = 0.004), and Tie2 (P = 0.02) compared with that in normal breast tissues.
|
11309342 |
2001 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Immunofluorescent staining (n = 20 specimens) revealed the presence of Ang-2 protein in normal mucosa and tumor epithelium, but Ang-1 was expressed only in normal mucosa.
|
11571726 |
2001 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Our results indicate that the perturbation of Ang1 expression in tumors could be an effective method to control tumor growth by inhibiting tumor angiogenesis and that antisense RNA is an efficient way to inhibit Ang1 protein production in tumor cells.
|
11668472 |
2001 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The levels of vascular endothelial growth factor (VEGF), its receptors VEGFR1 and VEGFR2, and angiopoietin-1 mRNA tended to be higher in the mammary fat pad tumors than in the cranial tumors (1.5-, 1.5-, 3-, and 2-fold, respectively).
|
11948107 |
2002 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
In addition, to additionally investigate the issue of tumor dormancy we wished to assess the relationship between Mcm2 labeling index (LI) and the angiogenic factors angiopoietin-1 (Ang) and Ang-2.
|
11948116 |
2002 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
We examined Ang-1 and vascular endothelial growth factor (VEGF) gene expression in tumors from 45 esophageal cancer patients who underwent surgical resection.
|
12239588 |
2002 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
These results indicate that angiopoietin 1 promotes tumor angiogenesis and tumor vessel plasticity of human cervical cancer in mice.
|
12243755 |
2002 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
Expression of the VEGF protein and the Ang2 (but not Ang1) mRNA were strongly correlated with MVD (P <.05, P =.001) and tumor size (P <.05).
|
12808060 |
2003 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
In an additional experiment, to validate the paracrine effect of Ang-1, various mixtures of control cells and Ang-1-transfected cells were injected into livers, and tumor growth was assessed.
|
12810673 |
2003 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Moreover, the computer simulations enable analysis of the versatile effects of drugs on the growth and decay of both the tumor and the immature and mature blood vessels, as well as on the induction of an array of relevant growth factors such as angiopoietin-1 (Ang1), angiopoietin-2 (Ang2), vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF).
|
12831061 |
2002 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
In vivo, expression of the transgene resulted in prolonged survival and reduction of tumor volume (62%) and reduced the expression of VEGF (57.8%) and Tie-2 (15.4%) but not Ang-1 and Ang-2.
|
15015569 |
2004 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
The changes in Angiopoietin-1 and Angiopoietin-2 expression were evaluated in relation to tumor differentiation and changes in tumor vascularity.
|
15094228 |
2004 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
The vessel-stabilizing effect of angiopoietin-1 (Ang1)/Tie2 receptor signaling is a potential target for pro-angiogenic therapies as well as anti-angiogenic inhibition of tumor growth.
|
15781448 |
2005 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
We have observed that overexpression of angiopoietin-1 (Ang1) in both subcutaneous and intracranial xenograft models of malignant astrocytomas reproduces many of the vascular features of these tumors, including glomeruloid bodies.
|
16354591 |
2005 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
There is, however, little information on the function of the Ang1/Tie2 pathway in the non-stromal cells within human tumors.
|
17189382 |
2006 |
Neoplasms
|
0.100 |
GeneticVariation
|
group |
BEFREE |
These results correlate with a reduction in the proliferation marker Ki67 in the Ang-(1-7)-infused tumors when compared with the saline-infused tumor tissues.
|
17363603 |
2007 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Angiopoietin-1 targeted RNA interference suppresses angiogenesis and tumor growth of esophageal cancer.
|
18330951 |
2008 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
These results suggest that Ang1 alters tumor growth in a manner that is dependent on the adhesion of mural cells and their localization in the tumor environment.
|
19018775 |
2008 |
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
During inhibition of VEGF, however, both overexpression of Ang1* and administration of an engineered Ang-1 agonist (Bow-Ang1) strikingly protected tumors and vasculature from regression.
|
19082480 |
2009 |
Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Angiopoietin-1 overexpression modulates vascular endothelium to facilitate tumor cell dissemination and metastasis establishment.
|
19487284 |
2009 |